NMMCF:OTC-NMC Health Plc (USD)

COMMON STOCK | |

Last Closing

USD 0.0001

Change

0.00 (0.00)%

Market Cap

USD 0.02M

Volume

8.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
NCRRP NCR Corp Pref A

N/A

USD 137.98B
TGOPF 3i Group plc

-0.64 (-1.59%)

USD 36.34B
STMZF Scottish Mortgage Investment T..

+0.13 (+1.17%)

USD 17.37B
SHZHY Shenzhou International Group H..

+0.24 (+2.39%)

USD 16.46B
ADEVF Adevinta ASA

N/A

USD 13.34B
PSZKF Powszechna Kasa Oszczednosci B..

N/A

USD 13.13B
CLEGF Coles Group Ltd

N/A

USD 12.70B
PSHZF Pershing Square Holdings Ltd

-0.09 (-0.17%)

USD 11.73B
ELPQF El Puerto de Liverpool S.A.B. ..

N/A

USD 10.80B
CINSF China Taiping Insurance Holdin..

N/A

USD 10.35B

ETFs Containing NMMCF

UAE iShares MSCI UAE ETF 0.00 % 0.59 %

+0.06 (+0%)

USD 0.04B
XFEW:LSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -50.00% N/A N/A 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.00% N/A N/A 11% F
Trailing 12 Months  
Capital Gain -50.00% N/A N/A 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -50.00% N/A N/A 22% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 25,432.30% 99% N/A 99% N/A
Dividend Return 25,432.30% 99% N/A 99% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A 3% F 1% F
Risk Adjusted Return 14.71% 63% D 49% F
Market Capitalization 0.02M N/A N/A 8% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.